Gliomas are tumors that arise from glial cells, the supportive cells of the brain and spinal cord. Unlike neurons, which transmit signals throughout the nervous system, glial cells help maintain the brain’s environment, support nerve function, and remove cellular debris.

Since gliomas originate in these essential support cells, they can affect critical neurologic functions depending on their size and location.

After a biopsy confirms the diagnosis and identifies the tumor type and grade, clinicians tailor treatment recommendations to the individual patient. Factors such as tumor location, size, age, and overall health help determine the most appropriate approach.

Common treatment options include:

• Observation: Appropriate for certain slow-growing or asymptomatic tumors.
• Surgery: Often the first-line treatment, with the goal of removing as much tumor as possible while preserving neurologic function.
• Radiation therapy: Frequently used after surgery to target remaining tumor cells.
• Chemotherapy: Often combined with radiation or given afterward, particularly for higher-grade tumors.
• Targeted therapies and immunotherapies: Emerging approaches designed to attack specific tumor mutations or stimulate the immune system to fight cancer.

Decision No. 1: What Matters Most, Quality of Life or Maximum Survival?

According to Dr. Youssef, every treatment discussion begins with an honest conversation about a patient’s priorities.

“For every new patient that I see, I tell them exactly the same thing. When we talk about treatment, we’re talking about quality of life, and we’re talking about quantity of life. We can make you live a really long time, but if that long time is not quality for you, then why are we doing treatment in the first place?”

At the time of diagnosis, treatments that extend survival often align with preserving quality of life. However, that balance can become more complicated if the tumor progresses or recurs (comes back after treatment).

“Later down the line, when someone has progression, or someone has recurrence, or whatever we call it, that line will split. There will be treatments that we offer that are going to make you feel pretty crappy, while some of the treatments that we offer may be less aggressive and will maintain your quality of life,” Dr. Youssef explains to SurvivorNet.

When recurrence occurs, patients may face difficult questions about whether to undergo additional surgery, radiation, or chemotherapy.

“Patient needs to decide: are they going to do radiation again? Would they want a second surgery? Are they going to want the chemotherapy that is going to make them so fatigued and throw up and lose their hair? Is that quality of life for them?” Dr. Youssef says.

For many patients, the answer depends on their personal goals, tolerance, family circumstances, and definition of quality of life.

Decision No. 2: Is a Clinical Trial the Right Choice?

The second major discussion centers on participating in clinical trials.

While clinical trials are often associated with experimental drugs, they can also evaluate new surgical techniques, medical devices, treatment combinations, and innovative approaches to care. Dr. Youssef encourages patients interested in research opportunities to raise the topic early with their oncologist during their treatment journey.

“Clinical trials have a role, and we know they can extend life. They don’t cure a disease yet, but clinical trials do provide more treatment options, and being a patient who may be interested or eligible is important to let your doctor know upfront that clinical trials are something you would like to be considered for.”

Trial eligibility often depends on factors such as prior treatments, tumor characteristics, and timing.

RELATED: SurvivorNet’s Guide to Clinical Trials: What Are They and Are They Right for You?

Decision No. 3: How Quickly Should Treatment Start?

Although exploring every available option may seem appealing, Dr. Youssef emphasizes that time is often a critical factor in glioma care.

“The other important aspect to think about is time. Many of these tumors grow rapidly, and we need to make sure we’re not wasting time looking for a different treatment option. The standard of care is the standard of care for a reason. It works.”

For patients considering treatment at another institution or searching for experimental approaches, delaying proven therapies can sometimes do more harm than good.

“If I don’t have a clinical trial for you, I don’t want you going across the country looking for something that may work, but will extend your time before you start treatment by months. That’s not helpful for you.”

The message, Dr. Youssef says, is not that patients should avoid second opinions but that they should carefully weigh the potential benefits of alternative options against the risks of postponing treatment.

Questions to Bring to Your Next Appointment

Since every glioma diagnosis is unique, patients can benefit from coming to appointments prepared with questions that clarify priorities and available options.

SurvivorNet’s AI-powered tool, My Health Questions, cuts through that complexity by helping people understand what new therapies mean for them and how to discuss their concerns with their care teams.

Embedded throughout the SurvivorNet website, My Health Questions delivers structured, clinically grounded answers based on medical guidelines and expert-reviewed research. Users can type or speak their questions and receive responses tailored to their individual profiles, with suggested prompts available for anyone unsure where to start.

Designed to support both major treatment decisions and everyday concerns, the tool is backed by leading oncology specialists. It complements conversations with clinicians—helping patients arrive at appointments more informed, prepared, and confident.

Dr. Youssef recommends focusing on three key areas:

• What does quality of life mean for me during treatment?
• Am I eligible for a clinical trial?
• How soon should treatment start?

The answers can help patients and physicians make shared decisions that balance effectiveness, quality of life, and the urgency of treatment.

Learn more about SurvivorNet's rigorous medical review process.